MedTrace Logo

A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure

NCT05875649 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2023-07-05

No results posted yet for this study

Summary

Most of patients with acute myeloid leukemia achieved complete remission (CR) after primary induction chemotherapy, there were 20-30% patients without CR after first-induction. It was uncertain how to treat these patients. It was investigated in our study that these patients were re-induced with CLAG Regimen. The CR ratio, overall survival (OS) and relapsed-free survival (RFS) was statistically analysed in these patients.

Conditions

Interventions

COMBINATION_PRODUCT

CLAG

Acute myeloid leukemia patients are re-induced by CLAG Regimen after first-induction failure

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Principal Investigators

  • Xuejie Jiang, Doctor · Nanfang Hospital, Southern Medical University

Eligibility

Min Age
14 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-02
Primary Completion
2027-08-20
Completion
2027-12-20

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05875649 on ClinicalTrials.gov